Ren-Jing Huang1, Ching-Hsiang Lai2, Shin-Da Lee3,4, Wei-Che Wang5, Ling-Hui Tseng5, Yu-Pin Chen1, Shen-Wen Chang6, Ai-Hui Chung6, Hua Ting7,8,9. 1. Department of Medical Image and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan. 2. Department of Applied Information Sciences, Chung Shan Medical University, Taichung, Taiwan. 3. Department of Physical Therapy, Graduate Institute of Rehabilitation Science, China Medical University, Taichung, Taiwan. 4. Department of Occupational Therapy, Asia University, Taichung, Taiwan. 5. Department of Physical Medicine and Rehabilitation, Chung Shan Medical University Hospital, 110, Sec. 1, Jianguo N. Rd, Taichung, 40201, Taiwan. 6. Sleep Medicine Center, Chung Shan Medical University Hospital, 110, Sec. 1, Jianguo N. Rd, Taichung, 40201, Taiwan. 7. Department of Physical Medicine and Rehabilitation, Chung Shan Medical University Hospital, 110, Sec. 1, Jianguo N. Rd, Taichung, 40201, Taiwan. huating@csmu.edu.tw. 8. Sleep Medicine Center, Chung Shan Medical University Hospital, 110, Sec. 1, Jianguo N. Rd, Taichung, 40201, Taiwan. huating@csmu.edu.tw. 9. Institute of Medicine, Chung Shan Medical University, 110, Sec. 1, Jianguo N. Rd, Taichung, 40201, Taiwan. huating@csmu.edu.tw.
Abstract
PURPOSE: To assess the physiological meanings of the detrended fluctuation analysis (DFA) slope α and its relationship to spectral measures in heart rate variability, this study investigated changes of α and its corresponding spectral measures over various night-sleep stages. METHODS: The overall DFA α and natural-logarithm-transformed power values of the spectral parameters ln[high-frequency (HF)], ln[low-frequency (LF)], and ln[very-low-frequency (VLF)], and their relationship from one 5-min proper electrocardiography segment in each of pre-sleep-wakefulness (AWK), non-rapid eye movement stage 2 (N2), slow-wave (N3), the first and the latest rapid-eye movement sleep (REM1, and REM2), were computed in 93 otherwise healthy males (44.1 ± 7.7 years.) with wide-ranged apnea-hypopnea, periodic-limb movement and arousal indices (19.0 ± 20.9, 4.7 ± 9.9, and 10.7 ± 18.2 h, respectively). RESULTS: While ln(HF) dipped from AWK, N2, and N3 to REM1 then rebounded to the origin level at REM2, ln(VLF) dipped from AWK to N2, N3 trough, and then surged to levels surpassing AWKs and N2s at REM1 and REM2. ln(LF/HF), ln(VLF/HF), and α dipped from AWK and N2 to N3 trough, surged to levels surpassing AWKs, and N2s at REM1 then became attenuated at REM2. By general linear modeling, the relationship between α and the corresponding spectral values can be seen over various stages as α = b 0 + 0.147 × ln(VLF/HF) (R (2) = 0.766), regardless of age and sleep-sympathoexcitatory episodes. CONCLUSION: The REM sleep attenuations appeared in ln(HF) and its derivatives, such as ln(LF/HF), ln(VLF/HF), and the overall DFA slope α values. The quantitative function of ln(VLF/HF) describes the α values constantly for overnight sleep stages, and it is not affected by age, LF, PLM, and AHI. Our findings therefore suggest that in sleep studies with spectral HRV measures, ln(VLF/HF) as a surrogate of the overall DFA slope α should be calculated at the same time.
PURPOSE: To assess the physiological meanings of the detrended fluctuation analysis (DFA) slope α and its relationship to spectral measures in heart rate variability, this study investigated changes of α and its corresponding spectral measures over various night-sleep stages. METHODS: The overall DFA α and natural-logarithm-transformed power values of the spectral parameters ln[high-frequency (HF)], ln[low-frequency (LF)], and ln[very-low-frequency (VLF)], and their relationship from one 5-min proper electrocardiography segment in each of pre-sleep-wakefulness (AWK), non-rapid eye movement stage 2 (N2), slow-wave (N3), the first and the latest rapid-eye movement sleep (REM1, and REM2), were computed in 93 otherwise healthy males (44.1 ± 7.7 years.) with wide-ranged apnea-hypopnea, periodic-limb movement and arousal indices (19.0 ± 20.9, 4.7 ± 9.9, and 10.7 ± 18.2 h, respectively). RESULTS: While ln(HF) dipped from AWK, N2, and N3 to REM1 then rebounded to the origin level at REM2, ln(VLF) dipped from AWK to N2, N3 trough, and then surged to levels surpassing AWKs and N2s at REM1 and REM2. ln(LF/HF), ln(VLF/HF), and α dipped from AWK and N2 to N3 trough, surged to levels surpassing AWKs, and N2s at REM1 then became attenuated at REM2. By general linear modeling, the relationship between α and the corresponding spectral values can be seen over various stages as α = b 0 + 0.147 × ln(VLF/HF) (R (2) = 0.766), regardless of age and sleep-sympathoexcitatory episodes. CONCLUSION: The REM sleep attenuations appeared in ln(HF) and its derivatives, such as ln(LF/HF), ln(VLF/HF), and the overall DFA slope α values. The quantitative function of ln(VLF/HF) describes the α values constantly for overnight sleep stages, and it is not affected by age, LF, PLM, and AHI. Our findings therefore suggest that in sleep studies with spectral HRV measures, ln(VLF/HF) as a surrogate of the overall DFA slope α should be calculated at the same time.
Authors: N Takabatake; H Nakamura; O Minamihaba; M Inage; S Inoue; S Kagaya; M Yamaki; H Tomoike Journal: Am J Respir Crit Care Med Date: 2001-05 Impact factor: 21.405
Authors: Thomas Penzel; Jan W Kantelhardt; Ludger Grote; Jörg-Hermann Peter; Armin Bunde Journal: IEEE Trans Biomed Eng Date: 2003-10 Impact factor: 4.538
Authors: Eduardo Luiz Pereira da Silva; Rafael Pereira; Luciano Neves Reis; Valter Luis Pereira; Luciana Aparecida Campos; Niels Wessel; Ovidiu Constantin Baltatu Journal: Medicine (Baltimore) Date: 2015-01 Impact factor: 1.889